Pasithea Therapeutics (KTTA) Total Current Liabilities (2020 - 2026)

Pasithea Therapeutics' Total Current Liabilities history runs 7 years deep, the most recent figure standing at $1.5 million for Q1 2026.

• In Q1 2026, Total Current Liabilities fell 6.61% year-over-year to $1.5 million; the TTM figure through Mar 2026 stood at $1.5 million (down 6.61% YoY), while the FY2025 annual figure was $5.0 million, up 344.15% from the prior year.
• Total Current Liabilities came in at $1.5 million for Q1 2026 at Pasithea Therapeutics, down from $5.0 million in the prior quarter.
• In the past five years, Total Current Liabilities ranged from a high of $5.0 million in Q4 2025 to a low of $433684.0 in Q1 2022.
• A 5-year average of $1.8 million and a median of $1.6 million in 2025 frame the typical range for Total Current Liabilities.
• Across the five-year window, Total Current Liabilities jumped 389.33% in 2023 and plunged 67.69% in 2024, its largest moves.
• Pasithea Therapeutics' Total Current Liabilities stood at $1.9 million in 2022, then jumped by 40.29% to $2.6 million in 2023, then sank by 57.48% to $1.1 million in 2024, then surged by 344.15% to $5.0 million in 2025, then sank by 70.05% to $1.5 million in 2026.
• According to Business Quant data, Total Current Liabilities over the past three periods registered $1.5 million, $5.0 million, and $1.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison